TESA/IPA
Tesamorelin/Ipamorelin is a dual-compound research blend combining a synthetic 44-amino acid analog of growth hormone-releasing hormone (GHRH) with a selective 5-amino acid growth hormone secretagogue. Together, these compounds engage complementary receptor pathways — GHRH receptors and GHSR-1a respectively — allowing researchers to examine synergistic GH axis signaling in controlled laboratory models. Supplied as a lyophilized powder in a 3mL vial, it is intended exclusively for in vitro laboratory research by qualified scientific personnel.
This combination has been utilized in preclinical studies examining GHRH receptor binding, pituitary somatotroph cell function, selective GH secretagogue receptor activity, and complementary growth hormone axis signaling pathways — independent of the broader endocrine effects associated with endogenous GHRH and ghrelin activity.
Product Details
- Form: Lyophilized powder (for laboratory research)
- Amounts: 6mg TESA/3mg IPA per vial
- Purity: ≥ 98% (HPLC tested)
- Sequence: 44 amino acids (synthetic GHRH analogue)
- Molecular Weight: ~513.6 g/mol/~711.9 g/mol
- Intended Use: Laboratory research only
DISCLAIMER: This product is strictly to be used for scientific research use only. It is not for human consumption and the FDA has not approved the use for diagnostic, therapeutic, or medical purposes.
We recommend you review our Terms of Service if you have questions about product use.
